1.2 Emerging methodological standards: overview of current international benefit-risk initiatives

Speaker: Hans Hillege, CHMP member

1. Where are we today in the benefit-risk debate: from models to real implementation?

Workshop on regulatory and methodological standards to improve benefit/risk evaluation of medicines

26 February 2014


Leave a Reply

Your email address will not be published. Required fields are marked *